Rigel Pharmaceuticals (RIGL) Net Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 6,663.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,663.00 |
| Dec 31, 2025 | 38,130.00 |
| Sep 30, 2025 | 12,511.00 |
| Jun 30, 2025 | 10,387.00 |
| Mar 31, 2025 | 18,546.00 |
| Dec 31, 2024 | 13,564.00 |
| Sep 30, 2024 | 11,971.00 |
| Jun 30, 2024 | 4,982.00 |
| Mar 31, 2024 | -7,668.00 |
| Dec 31, 2023 | 10,632.00 |
| Sep 30, 2023 | 5,685.00 |
| Jun 30, 2023 | 8,516.00 |
| Mar 31, 2023 | -9,002.00 |
| Dec 31, 2022 | 11,442.00 |
| Sep 30, 2022 | -2,986.00 |
| Jun 30, 2022 | 15,276.00 |
| Mar 31, 2022 | -2,460.00 |
| Dec 31, 2021 | -11,927.00 |
| Sep 30, 2021 | 39,125.00 |
| Jun 30, 2021 | 137,754.00 |
| Dec 31, 2020 | -68,123.00 |
| Sep 30, 2020 | 188,514.00 |
| Mar 31, 2020 | 46,538.00 |
| Dec 31, 2019 | 40,798.00 |
| Sep 30, 2019 | 54,675.00 |
| Jun 30, 2019 | -4,053.00 |
| Mar 31, 2019 | 20,786.00 |
| Dec 31, 2018 | 15,714.00 |
| Sep 30, 2018 | -43,717.00 |
| Jun 30, 2018 | -116,180.00 |
| Dec 31, 2016 | -22,643.00 |
| Jun 30, 2016 | 146,882.00 |
| Jun 30, 2015 | 138,084.00 |
| Mar 31, 2015 | 225,456.00 |
| Jun 30, 2013 | -168,094.00 |